Cellectis (CLLS) IPO Opens Up Flat
Get Alerts CLLS Hot Sheet
Join SI Premium – FREE
Today's IPO for Cellectis (NASDAQ: CLLS) opened for trading at $41.50 after pricing priced its 5,500,000 American Depositary Shares (ADSs) IPO at $41.50 per ADS. The IPO size was raised from 4,750,000.
In addition, Cellectis has granted the underwriters a 30-day option to purchase up to an additional 825,000 ADSs.
BofA Merrill Lynch, Jefferies and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Oppenheimer & Co. and Trout Capital are acting as co-managers for the offering.
Cellectis is a gene-editing company, which employs its core proprietary technologies to develop best-in-class products in the emerging field of immuno-oncology.
Oil pr
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Marex Group (MRX) Prices 15.38M Share IPO at $19/sh
- YY Group Holding (YYGH) Closes $5M IPO
- AZZ, Inc. (AZZ) Announces Proposed 4M Share Offering
Create E-mail Alert Related Categories
Hot IPOs, IPOsRelated Entities
Piper Jaffray, Jefferies & Co, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!